$36B
Global regenerative medicine market size projected for 2026
Source: Grand View Research, Regenerative Medicine Market Outlook 2026
Who We Serve
Regenerative Medicine Doctors
Regenerative medicine physicians replace surgery and long-term medication with biologics, energy-based devices, and precision peptide protocols that stimulate the body's own repair pathways.
Regenerative medicine doctors are board-certified physicians — often orthopedists, sports-medicine, PM&R, urologists, gynecologists, aesthetic physicians, or interventional pain specialists — who use platelet-rich plasma, exosomes, mesenchymal stem cells (MSCs), amniotic tissue allografts, shockwave, laser, and peptide therapy to accelerate healing, reduce inflammation, and restore function. Instead of masking symptoms, they target the underlying biology of joint degeneration, tendon and ligament injury, chronic pain, hair loss, sexual dysfunction, skin aging, and post-surgical recovery.
By the numbers
2026 stats you should know
17.4%
2026 CAGR for platelet-rich plasma (PRP) globally
Source: Fortune Business Insights, PRP Market Report 2026
62%
US regenerative practices offering exosome therapy in 2026 (up from 41% in 2024)
Source: American Academy of Regenerative Medicine 2026 Practice Survey
1 in 3
Knee osteoarthritis patients now offered biologics before considering arthroplasty
Source: AAOS 2026 Clinical Practice Trends Report
Benefits
Non-surgical alternatives that keep patients working
PRP, MSCs, exosomes, and ECSWT reduce or eliminate the need for cortisone, opioids, and elective surgery for knee osteoarthritis, rotator cuff, tennis elbow, plantar fasciitis, and chronic tendinopathies.
Faster recovery with lower complication risk
Autologous and allograft biologics carry a low adverse-event profile and can be combined with shockwave or laser to shorten rehab timelines versus arthroscopic surgery.
Higher per-patient revenue with cash-pay procedures
Regenerative procedures are largely cash-pay, which supports pricing transparency, no insurance denials, and predictable margin.
Wide clinical scope from one dispensary
The same practice can treat orthopedic pain, sexual wellness, hair restoration, aesthetics, and wound care using overlapping biologics and devices — increasing lifetime patient value.
How they help patients
- Knee, hip, shoulder, and spine osteoarthritis without joint replacement
- Tendon and ligament injuries: rotator cuff, tennis elbow, Achilles, plantar fasciitis
- Sexual wellness: erectile dysfunction, Peyronie's, female sexual dysfunction
- Aesthetics: facial rejuvenation, scar revision, stretch marks, hair restoration
- Chronic wounds, post-surgical scars, and diabetic ulcers
- Post-workout recovery, sports performance, and injury prevention
Tools & Services Regenerative Doctors Use
We supply the full regenerative stack — biologics, energy-based devices, sterile consumables, and AI peptide protocols — through one clinical partner.
Biologics
PRP, exosomes, MSCs, and amniotic allografts for joints, tendons, sexual wellness, aesthetics, and wound care.
Devices
Focused shockwave (ECSWT), high-power laser (HPLT), low-level laser (LLLT), microneedling, and fractional dermal infusion.
Peptide protocols
AI-guided GLP-1, healing, sexual-health, and longevity peptide protocols with clinician education.
Supplies, PPE & technologies
Injection kits, single-use sterile consumables, PPE, and practice technology to run a compliant procedure suite.
How we onboard your practice
- Step 1Consultation
Practice assessment: patient panel, procedure mix, room and staff readiness.
- Step 2Onboarding
Biologics, devices, and peptide protocols tailored to your specialty, plus staff training.
- Step 3Ongoing support
Restocking, protocol updates, and marketing support via our partner network.
Frequently asked questions
Do regenerative procedures replace surgery?
For many orthopedic, tendon, and sexual-wellness indications, biologics and shockwave can defer or replace surgery. We help you triage which patients are candidates.
Are these treatments FDA-approved?
PRP and shockwave devices we supply are FDA-cleared for their labeled indications. Cellular and amniotic products are provided under applicable HCT/P regulations.
Can I combine biologics with peptides?
Yes — many practices combine PRP or MSCs with GLP-1, BPC-157, or growth-hormone-releasing peptides. Our partners at PeptideProtocols.ai and PepEdHub.com support protocol design.
From the blog
Latest articles for Regenerative Medicine Doctors
January 14, 2026 · 8 min read
Regenerative Medicine in 2026: What Physicians Need to Stock, Bill, and Believe
The 2026 regenerative stack is bigger than PRP. Here's the biologics, devices, and peptide combinations that are actually moving outcomes and revenue this year.
Read article →February 20, 2026 · 6 min read
PRP vs. Exosomes vs. MSCs in 2026: How to Actually Choose
A practical, indication-by-indication decision framework for regenerative physicians choosing between PRP, exosomes, MSCs, and amniotic tissue in 2026.
Read article →Build a full regenerative service line
Tell us your specialty and patient volume. We'll recommend the right biologics, devices, and peptide protocols and support onboarding end to end.